Robert Cipolla
Procedural Dermatology · Staten Island, NYNPI 1710443015
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $220 of the $249 with a category attached, or 88.3%. It is spread thinly across 9 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for procedural dermatology clinicians in NY, where the typical reported total is $3,601.
Across 14 payments — averaging $17.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$58
- Novartis$47
- Amgen$37
- Organon$30
- Galderma Laboratories, L.p.$18
- Pfizer$15
- plus $43 from 3 others
What the payments were for
- Food & beverage$22088%
- Education$2912%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 2 | $58 |
| Novartis | 2 | $47 |
| Amgen | 2 | $37 |
| Organon | 3 | $30 |
| Galderma Laboratories, L.p. | 1 | $18 |
| Pfizer | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| LEO Pharma Inc. | 1 | $15 |
| Dermavant Sciences, Inc. | 1 | $14 |
How this compares
$249 in reported general payments places this provider in the 20th percentile of 69 procedural dermatology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 24 | $89,795 |
| Taltz AutoinjectorIxekizumab | 13 | $84,142 |
| Dupixent PenDupilumab | 15 | $55,656 |
| Clobetasol Propionate | 293 | $16,529 |
| Triamcinolone Acetonide | 383 | $5,059 |
| Halobetasol Propionate | 82 | $4,844 |
| Mupirocin | 593 | $4,336 |
| Metronidazole | 51 | $3,614 |
| Ketoconazole | 209 | $3,518 |
| Clindamycin Phosphate | 94 | $3,335 |
| Calcipotriene | 16 | $3,138 |
| Cephalexin | 60 | $2,768 |
| Tacrolimus | 19 | $2,659 |
| Econazole Nitrate | 67 | $2,314 |
| Ammonium Lactate | 78 | $2,235 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Staten Island
- Joseph SchwartzTroy$470K
- Michelle HenryNew York$460K
- Jerry ShapiroNew York$414K
- Jared JagdeoBrooklyn$362K
- Dendy EngelmanNew York$292K
- Evan RiederNew York$210K
- Daniel Belkin-HollandNew York$208K
- Suzanne Sirota-RozenbergWoodmere$122K
- Robert BacigalupiGarden City$109K
- Anthony ChiaravallotiEast Syracuse$90K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.